Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 18, 2009
- Accepted for publication July 13, 2009
- Published online February 1, 2010.
Article Versions
- previous version (January 15, 2010 - 06:02).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2010 by Society of Nuclear Medicine
Author Information
- Perrine Tylski 1 ,
- Simon Stute 1 ,
- Nicolas Grotus 1 ,
- Kaya Doyeux 2 ,
- Sébastien Hapdey 2 ,
- Isabelle Gardin 2 ,
- Bruno Vanderlinden 3 and
- Irène Buvat 1
- 1IMNC UMR 8165 CNRS–Paris 7 and Paris 11 Universities, Orsay, France; 2LITIS EA 4108 Laboratory, University of Rouen, Rouen, France; and 3Nuclear Medicine Department, Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium
- For correspondence or reprints contact: Perrine Tylski, IMNC, Campus d'Orsay, Bâtiment 104, 91406 Orsay Cedex, France. E-mail: tylski{at}imnc.in2p3.fr
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden
- Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma
- 18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer
- Subcentimeter Tumor Lesion Delineation for High-Resolution 18F-FDG PET Images: Optimizing Correction for Partial-Volume Effects
- Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET
- 18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
- Prognostic PET 18F-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
- Kinetic Analysis of 18F-FLT PET in Lung Tumors
- Nonlaxative PET/CT Colonography: Feasibility, Acceptability, and Pilot Performance in Patients at Higher Risk of Colonic Neoplasia
- SUV: From Silly Useless Value to Smart Uptake Value